The American Society of Hematology (ASH) recently opened draft recommendations for Treatment of AL Amyloidosis. Individuals interested in providing feedback are welcome to do so by submitting their feedback via email to the email address provided in the link below. ASH encourages all interested member and non-members, including healthcare professionals, stakeholders, and patients, to participate in providing feedback.
Click here to gain access to the draft recommendations.
The public comment window is open through July 7, 2026.